Preeclampsia: Effect on the fetus and newborn

NeoReviews

Volumn 12, Issue 4, 2011, Pages

  Rugolo, Ligia Maria Suppo de Souza ^a   Bentlin, Maria Regina ^a   Trindade, Cleide Enoir Petean ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79959875420     PISSN: None     EISSN: 15269906     Source Type: Journal    
DOI: 10.1542/neo.12-4-e198     Document Type: Article

References (46)

1. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005; 365:785-799
2. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33:130-137
3. Silasi M, Cohen B, Karumanchi AS, Rana S. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin North Am. 2010;37:239-253
4. Roberts CL, Algert CS, Morris JM, Ford JB, Henderson-Smart DJ. Hypertensive disorders in pregnancy: a population based study. MJA. 2005;182:332-335
5. Villar J, Carroli G, Wojdyla D, et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol. 2006;194:921-931
6. Hernandez-Dias S, Toh S, Canttingius S. Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ. 2009;338:e2255
7. Report of National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183:S1-S22
8. Laresgoiti-Servitje E, Gomez-Lopez N, Olson DM. An immunological insight into the origins of pre-eclampsia. Hum Reprod Update. 2010;16:510-524
9. Borzychowski AM, Sargent IL, Redman CWG. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med. 2006;11:309-316
10. Rui-qiong MA, Min-na S, Zi Y. Effects of preeclampsia-like symptoms at early gestational stage on feto-placental outcomes in a mouse model. Chin Med J. 2010;123:707-712
11. Trindade CEP, Rugolo LMSS. Free radicals and neonatal diseases. NeoReviews. 2007;8:522-532
12. Brosens JJ, Pijnenborg R, Brosens IA. The myometrial junction zone spiral arteries in normal and abnormal pregnancies: a review of the literature. AmJ Obstet Gynecol. 2002;187:1416-1423
13. Cindrova-Davies T. Gabor Than award lecture 2008: Preeclampsia-from placental oxidative stress to maternal endothelia dysfunction. Placenta. 2009;23(suppl A):S55-S66
14. Chamy VM, Lepe J, Catalan A, Retamal D, Escobar JA, Madrid EM. Oxidative stress is closely related to clinical severity of pre-eclampsia. Biol Res. 2006;39:229-236
15. Kaur G, Mishra S, Sehgal A, Prasad R. Alterations in lipid peroxidation and antioxidant status in pregnancy with preeclampsia. Mol Cell Biochem. 2008;313:37-44
16. Boutet M, Roland L, Thomas N, Bilodeau JF. Specific systemic antioxidant response to preeclampsia in late pregnancy: the study of intracellular glutathione peroxidases in maternal and fetal blood. Am J Obstet Gynecol. 2009;200:530. e1-530. e7
17. Nishizawa H, Pryor-Koishi K, Suzuki M, et al. Analysis of nitric oxide metabolism as a placental or maternal factor underlying the etiology of pre-eclampsia. Gynecol Obstet Invest. 2009;68:239-247
18. Dikensoy E, Balat O, Pence S, Balat A, Cekmen M, Yurekli M. The changes of plasma malondialdehyde, nitric oxide, and adrenomedullin levels in patients with preeclampsia. Hypertens Pregnancy. 2009;28:383-389
19. Villar J, Purwar M, Merialdi M, et al. World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at risk for pré-eclampsia in populations of low nutritional status from developing countries. BJOG. 2009;116:780-788
20. Mistry HD, Kurlak LO, Williams PJ, Ramsay MM, Symonds ME, Pipkin FB. Differential expression and distribution of placental glutathione peroxidases 1, 3 and 4 in normal and preeclamptic pregnancy. Placenta. 2010;31:401-408
21. Howlader ZH, Parveen S, Tamanna S, Khan TA, Begum F. Oxidative stress and antioxidant status in neonates born to preeclamptic mother. J Trop Pediatr. 2009;55:363-367
22. Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble VEGF receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008;21:9-23
23. Kulkarni AV, Mehendale SS, Yadav HR, Kilari AS, Taralekar VS, Joshi SR. Circulating angiogenic factors and their association with birth outcomes in preeclampsia. Hypertens Res. 2010;33: 561-567
24. Goyal R, Yellon SM, Longo LD, Mata-Greenwood E. Placental gene expression in a rat "model" of placental insufficiency. Placenta. 2010;31:568-575
25. Koopmans CM, Bijlenga D, Groen H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild preeclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009;374: 979-988
26. Coletta J, Simpson LL. Maternal medical disease and stillbirth. Clin Obstet Gynecol. 2010;53:607-616
27. Haddad B, Sibai BM. Expectant management in pregnancies with severe pré-eclampsia. Semin Perinatol. 2009;33:143-151
28. Churchill D, Duley L. Interventionist versus expectant care for severe pre-eclampsia before term. Cochrane Database Syst Rev. 2010;4:CD003106
29. Shah DM. Perinatal implications of maternal hypertension. Semin Pediatr Neurol. 2001;8:108-119
30. Gasem T, al Jama FE, Burshaid S, Rahaman J, Al Suleiman AS, Rahamn MS. Maternal and fetal outcome of pregnancy complicated by HELLP syndrome. J Matern Fetal Neonatal Med. 2009;22: 1140-1143
31. Zupan-Simunek V. Prognosis in newborns after mother's preeclampsia. Ann Fr Anesth Reanim. 2010;29:e135-e139
32. Ray JG, Burrows RF, Burrows EA, Vermeulen MJ. MOS HIP: McMaster Outcome Study of Hypertension in Pregnancy. Early Hum Dev. 2001;64:129-143
33. Mitani M, Matsuda Y, Makino Y, Akizawa Y, Ohta H. Clinical features of fetal growth restriction complicated later by preeclampsia. J Obstet Gynaecol Res. 2009;35:882-887
34. Srinivas SK, Edlow AG, Neff PM, Sammel MD, Andrela CM, Elovitz MA. Rethinking IUGR in preeclampsia: dependent or independent of maternal hypertension. J Perinatol. 2009;29:680-684
35. Soto E, Romero R, Richani K, et al. Preeclampsia and pregnancies with small for gestational age neonates have different profiles of complement split products. J Matern Fetal Neonatal Med. 2010;23:646-657
36. Schiff E, Friedman SA, Mercer BM, Sibbai BM. Fetal lung maturity is not accelerated in preeclamptic pregnancies. Am J Obstet Gynecol. 1993;169:1096-1101
37. Silveira RC, Procianoy RS, Koch AS, Benjamin AC, Schindwein AF. Growth and neurodevelopment outcome of very low birth weight infants delivered by preeclamptic mothers. Acta Paediatr. 2007;96:1738-1742
38. Bath YR, Cherian CS. Neonatal thrombocytopenia associated with maternal pregnancy induced hypertension. Indian J Pediatr. 2008;75:571-573
39. Sharma G, Nesin M, Feuerstein M, Bussel JB. Maternal and neonatal characteristics associated with neonatal neutropenia in hypertensive pregnancies. Am J Perinatol. 2009;26:683-690
40. Procianoy RS, Silveira RC, Mussi-Pinhata MM, et al for the Brazilian Network on Neonatal Research. Sepsis and neutropenia in very low birth weight infants delivered of mothers with preeclampsia. J Pediatr. 2010;157:434-438
41. Bashiri A, Zmora E, Sheiner E, Hershkovitz R, Shoham-Vardi I, Mazor M. Maternal hypertensive disorders are an independent risk factor for the development of necrotizing enterocolitis in very low birth weight infants. Fetal Diagn Ther. 2003;18: 404-407
42. Impey L, Greenwood C, Sheil O, MacQuillan K, Reynolds M, Redman C. The relation between pre-eclampsia at term and neonatal encephalopathy. Arch Dis Child Fetal Neonatal Ed. 2001;85: F170-F172
43. Paul DA, Kepler J, Leef KH, Siscione A, Palmer C, Stefano JL. Effect of preeclampsia on mortality, intraventricular hemorrhage, and need for mechanical ventilation in very low birth weight infants. Am J Perinatol. 1998;15:381-386
44. Ancel PY, Marret S, Larroque B, et al. Are maternal hypertension and small-for-gestational age risk factors for severe intraventricular hemorrhage and cystic periventricular leukomalacia? Results of the EPIPAGE cohort study. Am J Obstet Gynecol. 2005;193: 178-184
45. FineSmith RB, Roche K, Yellin PB, et al. Effect of magnesium sulfate on the development of cystic periventricular leukomalacia in preterm infants. Am J Perinatol. 1997;14:303-307
46. Robinson M, Mattes E, Oddy WH, et al. Hypertensive diseases of pregnancy and the development of behavioral problems in childhood and adolescence: the Western Australian Pregnancy Cohort Study. J Pediatr. 2009;154:218-224